Isoprostanes

Bioactive Lipids

Volumn , Issue , 2012, Pages 265-285

  Basu, Samar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750502782     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9780857097934.265     Document Type: Chapter

References (124)

1. Aleynik S.I., Leo M.A., Ma X., Aleynik M.K., Lieber C.S. Polyenylphosphatidyl choline prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 1997, 27:554-561.
2. Aleynik S.I., Leo M.A., Aleynik M.K., Lieber C.S. Increased circulating products of lipid peroxidation in patients with alcoholic liver disease. Alcohol Clin Exp Res 1998, 22:192-196.
3. 13-reductase in the tissue of swine. Acta Physiol Scand 1971, 240:3518-3521.
4. 2-isoprostanes. J Nutr 1994, 124:810-816.
5. 2α in rabbit lung in situ. Am J Physiol 1992, 263:H660-H663.
6. Barden A., Beilin L.J., Ritchie J., Croft K.D., Walters B.N., Michael C.A. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy. Clin Sci (London) 1996, 91:711-718.
7. 2α in the rabbit. Prost Leuk Ess Fatty Acids 1997, 57:267.
8. 2α: An index for oxidative injury via free radical catalysed lipid peroxidation. Prost Leuk Ess Fatty Acids 1998, 58:319-325.
9. 2α: An index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prost Leuk Ess Fatty Acids 1998, 58:347-352.
10. 2α. FEBS Lett 1998, 428:32-36.
11. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 1999, 254:764-767.
12. Basu S. Carbon tetrachloride induced lipid peroxidation: Eicosanoid formation and its regulation by antioxidants. Toxicology 2003, 189:113-127.
13. 2α formation in the rabbit. Free Radic Res Abs 2003, 27:79.
14. Basu S., Eriksson M. Retinol palmitate counteracts oxidative injury during experimental septic shock. Annals Acad Sci (Singapore) 2000, 30:265-269.
15. 13-reductase dependent metabolism of prostaglandins in the mammalian brain and eye. Prost Leuk Ess Fatty Acids 1997, 57:305-310.
16. 13-reductase in porcine cornea. Acta Chem Scand 1992, 46:108-110.
17. Basu S., Smedman A., Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 2000, 468:33-36.
18. Basu S., Risérus U., Turpeinen A., Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (London) 2000, 99:511-516.
19. Basu S., Larsson A., Mattsson C., Eriksson O., Kiiski R., Nordgren A., Eriksson M. Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock. Exp Opin Invest Drugs 2000, 9:1129-1137.
20. Basu S., Michaelsson K., Olofsson H., Johansson S., Melhus H. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001, 288:275-279.
21. 2α in different rheumatic diseases. Ann Rheum Dis 2001, 60:627-631.
22. Basu S., Mutschler D.K., Larsson A.O., Kiiski R., Nordgren A., Eriksson M.B. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001, 50:341-348.
23. 2α in anaesthesized guinea pigs. Pharmacol Res 1998, 37:75-80.
24. 2α. Prost Leuk Ess Fatty Acids 2001, 64:307-310.
25. 2α. J Biol Chem 1999, 274:1313-1319.
26. Ciabattoni G., Davi G., Collura M., Iapichino L., Pardo F., Ganci A., Romagnoli R., Maclouf J., Patrono C. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:1195-1201.
27. Cipollone F., Ciabattoni G., Patrignani P., Pasquale M., Di Gregorio D., Bucciarelli T., Davi G., Cuccurullo F., Patrono C. Oxidant stress and aspirin insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000, 102:1007-10013.
28. 2-isoprostane in cystic fibrosis. Lipids 1999, 34:551-572.
29. 2-isoprostanes in patients with severe heart failure. Heart 2000, 84:439-440.
30. Cracowski J.L., Marpeau C., Carpentier P.H., Imbert B., Hunt M., Stanke-Labesque F., Bessard G. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders. Arthritis Rheum 2001, 44:1143-1148.
31. 2-isoprostanes in systemic sclerosis but not in primary Raynaud's phenomenon. Effect of a cold exposure. Arthritis Rheum 2001, 46:1319-1323.
32. Cracowski J.L., Cracowski C., Bessard G., Pepin J.L., Bessard J., Schwebel C., Stanke-Labesque F., Pison C. Increased lipid peroxidation in patients with pulmonary hypertension. Am J Crit Care Med 2001, 164:1248-1252.
33. 2α is increased in hypercholesteromia. Arterioscler Thromb Vasc Biol 1997, 17:3230-3235.
34. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999, 99:224-229.
35. Davi G., Di Minno G., Coppola A., Andria G., Cerbone A.M., Madonna P., Tufano A., Falco A., Marchesani P., Ciabattoni G., Patrono C. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 2001, 104:1124-1128.
36. 2α generation during coronary reperfusion. Circulation 1997, 95:2492-2499.
37. Dragstedt L.O., Pedersen A., Hermetter A., Basu S., Hansen S., Ravn-Haren G., Kall M., Breinholt V., Castenmiller J., Stagsted J., Jakobsen J., Skibsted L.H., Loft S.E., the late Sandström B. The 6-a-day study: Effects of fruits and vegetables on markers of oxidative stress and defense in healthy non-smokers. Am J Clin Nutr 2004, 79:1060-1072.
38. 2α, an in vivo marker of oxidative stress in aged rats. Free Radic Biol Med 1999, 27:463-469.
39. 2α or nitric oxide metabolites during a high-linoleic acid diet in healthy females. Eur J Nutr 1999, 38:149-157.
40. Freese R., Alfthan G., Jauhiainen M., Basu S., Erlund I., Salminen I., Aro A., Mutanen M. High intakes of vegetables, berries and apple combined with high intake of linoleic acid or oleic acid only slightly effect markers of lipid peroxidation or lipoprotein metabolism in healthy subjects. Am J Clin Nutr 2002, 76:950-960.
41. 2-isoprostanes are present in increased amounts in human atherosclerotic lesions. Arterioscl Throm Vas Biol 1997, 17:2975-2981.
42. Gopaul N.K., Änggård E.E., Mallet A.I., Betteridge D.J., Wolff S.P., Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 1995, 17:225-229.
43. 2-isoprostanes as index of lipid peroxidation does not appear to be confounded by diet. Free Radic Res 2000, 33:115-117.
44. Gutteridge J.M.C., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990, 15:129-135.
45. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?. Lancet 1994, 10:721-724.
46. Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward?. Cardiovasc Res 2000, 47:410-418.
47. Halliwell B., Gutteridge J.M.C. Free Radical Biology and Medicine 1999, Oxford University Press, New York. 3.
48. 2α excretion rate and diurnal variation in urine in normal subjects. Prost Leuk Ess Fatty Acids 1999, 61:203-205.
49. 2α metabolite excretion rate and day to day variation in healthy humans. Prost Leuk Ess Fatty Acids 2001, 65:99-102.
50. 2α metabolite levels in men with migraine. Clin Sci (London) 2002, 102:39-43.
51. Helmersson J., Vessby B., Larsson A., Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidtive stress in an elderly population. Circulation 2004, 109:1729-1734.
52. 2-isoprostanes. Am J Clin Nutr 2000, 72:714-722.
53. Hoffman S.W., Moore S., Ellis E.F. Isoprostanes: free radical-generated PGs with constrictor effects on cerebral arteries. Stroke 1997, 28:844-849.
54. Ide T., Tsutsui H., Ohashi N., Hayashidani S., Suematsu N., Tsuchihashi M., Tamai H., Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 2002, 22:438-442.
55. Ingail A., Lott K.A., Slater T.F. Metabolic activation of carbon tetrachloride to a free-radical product: studies using a spin trap. Biochem Soc Trans 1978, 6:962-978.
56. Ishihara O., Hayashi M., Osawa H., Kobayashi K., Takeda S., Vessby B., Basu S. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and nonpregnancy. Free Radical Res 2004, (in press).
57. 2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001, 37:76-80.
58. 2α on retinal blood vessels. Am J Physiol 1998, 274:R1406-R1416.
59. Lawson J.A., Rokach J., FitzGerald G.A. Isoprostanes: Formation, analysis and use of indices of lipid peroxidation in vivo. J Biol Chem 1999, 27:24441-24444.
60. Levine M., Wang Y., Padayatty S.J., Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci USA 2001, 98:9842-9846.
61. 2, on the platelet thromboxane/endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor. Prostaglandins 1994, 48:247-256.
62. 2α in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure. Circulation 1998, 97:1536-1539.
63. Meagher E.A., Barry O.P., Burke A., Lucey M.R., Lawson J.A., Rokach J., FitzGerald G.A. Alcohol induced generation of lipid peroxidation products in humans. J Clin Invest 1999, 104:805-813.
64. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. J Am Med Assoc 2001, 285:1178-1182.
65. 2α, is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovasc Res 1999, 43:492-499.
66. Monga M., Dunn K., Rajasekaran M. Characterization of ultrastructural and metabolic abnormalities in semen from men with spinal cord ischemia. J Spinal Cord Med 2001, 24:41-46.
67. 2-isoprostane concentration in probable AD. Neurology 1999, 52:562-565.
68. 2-isoprostanes are elevated in Huntington's disease. Neurology 1999, 52:1104-1105.
69. Montine T.J., Markesbery W.R., Zackert W., Sanchez S.C., Roberts L.J., Morrow J.D. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with the density of the neuritic plaques and neorofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol 1999, 155:863-868.
70. 2-isoprostanes among patients with Huntington's or Alzheimer's disease. Ann Neurol 2000, 48:950.
71. Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., du Bois R.M., Kharitonov S.A., Barnes P.J. 8-isoprostane as biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998, 158:1524-1527.
72. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999, 160:216-220.
73. Montuschi P., Collins J.V., Ciabattoni G., Lazzeri N., Corradi M., Kharitonov S.A., Barnes P.J. Exhaled 8-isoprostane as in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000, 162:1175-1177.
74. Montuschi P., Kharitonov S.A., Ciabattoni G., Corradi M., van Rensen L., Geddes D.M., Hodson M.E., Barnes P.J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000, 55:205-209.
75. 2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 1999, 48:1402-1408.
76. Morris J.M., Gopaul N.K., Endresen M.J., Knight M., Linton E.A., Dhir S., Anggard E.E., Redman C.W. Circulating markers of oxidative stress raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998, 105:1195-1199.
77. Morrow J.D. The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev 2000, 32:377-385.
78. Morrow J.D., Roberts L.J. The isoprostanes. Current knowledge and directions of future research. Biochem Pharmacol 1996, 51:1-9.
79. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism. Proc Natl Acad Sci USA 1990, 87:9383-9387.
80. Morrow J.D., Harris T.M., Roberts L.J. Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramification of for measurement of eicosanoids. Anal Biochem 1990, 184:1-10.
81. 2-isoprostanes) are formed in situ on phosphlipids. Proc Natl Acad Sci USA 1992, 89:10721-10725.
82. 4 hepatotoxicity. J Clin Invest 1992, 90:2502-2507.
83. 2α, is formed in vivo. Biochim Biophys Acta 1994, 1210:244-248.
84. Morrow J.D., Minton T.A., Mukundan C.R., Campbell M.D., Zackert W.E., Daniel V.C., Badr K.F., Blair I.A., Roberts L.J. Free radical-induced generation of isoprostanes in vivo. J Biol Chem 1994, 269:4317-4326.
85. 2-isoprostanes) in smokers. N Eng J Med 1995, 332:1198-1203.
86. Murai Y., Hishinuma T., Suzuki N., Satoh J., Toyota T., Mizugaki M. Determination of 8-epi prostaglandin F (2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics. Prost Other Lipid Mediators 2000, 62:173-181.
87. Mutschler D.K., Eriksson M.B., Wikström B.G., Lind L., Larsson A., Bergren-Kiiski R., Lagrange A., Nordgren A., Basu S. Microdialysis-evaluated myocardial COX-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 2003, 31:1780-1785.
88. 1. Recl Trav Chim Pays-Bas 1967, 86:1237-1245.
89. O'Byrne S., Forte P., Roberts L.J., Morrow J.D., Johnston A., Änggård E., Leslie R.D., Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000, 49:857-862.
90. O'Connor D.E., Mihelich E.D., Coleman M.C. Stereochemical course of the autooxidised cyclization of the lipid hydroperoxides to prostaglandin-like bicyclo endoperoxides. J Am Chem Soc 1984, 106:3577-3584.
91. Oguogho A., Lupattelli G., Palumbo B., Sinzinger H. Isoprostanes quickly normalize after quitting cigarette smoking. Vasa 2000, 29:103-105.
92. 2-isoprostane and thromboxane biosynthesis in healthy subjects. Circulation 2000, 102:539-545.
93. Porter N.A., Funk M.O. Peroxy radical cyclization as a model for prostaglandin synthesis. J Org Chem 1975, 40:3614-3615.
94. 2-isoprostanes in human atherosclerotic patients. J Clin Invest 1997, 100:2028-2034.
95. Pratico D., Iuliano L., Basili S., Ferro D., Camastra C., Cordova C., FitzGerald G.A., Violi F. Enhanced lipid peroxidation in hepatic cirrhosis. J Investig Med 1998, 46:51-57.
96. 2α-I: An index of lipid peroxidation in humans. Proc Natl Acad Sci USA 1998, 95:3449-3454.
97. 2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 1998, 12:1777-1783.
98. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nature Med 1998, 4:1189-1192.
99. 2α-VI in Alzheimer's disease: correlation of a non-invasive index of lipid peroxidation with disease severity. Ann Neurol 2000, 48:809-812.
100. Regan C.L., Levine R.J., Baird D.D., Ewell M.G., Martz K.L., Sibai B.M., Rokach J., Lawson J.A., Fitzgerald G.A. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynaecol 2001, 185:572-578.
101. Reilly M., Delanty N., Lawson J.A., FitzGerald G.A. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996, 94:19-25.
102. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 1997, 96:3314-3320.
103. Richelle M., Turini M.E., Guidoux R., Tavazzi I., Metairon S., Fay L.B. Urinary isoprostane excretion is not confounded by the lipid content of diet. FEBS Lett 1999, 459:259-262.
104. Risérus U., Basu S., Jovinge S., Fredrikson G.N., Arnlov J., Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. A potential link to fatty acid-induced insulin resistance. 0: Circulation 2002, 106:1925-1929.
105. 2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000, 28:505-513.
106. Roberts L.J., Morrow J.D. Products of isoprostane pathway: Unique bioactive compounds and markers of lipid peroxidation. Cell Mol Life Sci 2002, 59:808-820.
107. 2α in humans. J Biol Chem 1996, 271:20617-20620.
108. Roberts L.J., Oates J.A., Fazio S., Gross M.D., Linton M.F., Morrow J.D. A-Tocopherol supplementation reduces F2-isoprostane concentrations in hypercholesterolemic humans only at doses of 800 IU or higher. Free Radic Biol Med 2002, 33(2):S412.
109. Sinzinger H. Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared to non-smokers. Lymphology 2000, 33:24-31.
110. Smedman A., Vessby B., Basu S. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by α-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (London) 2004, 106:67-73.
111. 2α in the rat. J Nutr 1999, 130:10-14.
112. 2-isoprostanes after hydrolysis of lipids in tissues. Prost Leuk Ess Fatty Acids 2000, 63:149-152.
113. Södergren E., Cederberg J., Vessby B., Basu S. Reduction of non-enzymatic and enzymatic lipid peroxidation with vitamin E supplementation in experimental hepatotoxicity. Eur J Nutr 2001, 40:10-16.
114. Stein C.M., Tanner S.B., Awad J.A., Roberts L.J., Morrow J.D. Evidence of free radical mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996, 39:1146-1150.
115. 2 receptors. J Clin Invest 1992, 90:131-141.
116. Turpeinen A.M., Basu S., Mutanen M. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prost Leuk Ess Fatty Acids 1998, 59:229-233.
117. Ulus A.T., Aksoyek A., Ozkan M., Katircioglu S.F., Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med 2003, 34:911-917.
118. Vessby J., Basu S., Mohsen R., Berne C., Vessby B. Oxidative stress and antioxidant status in Type 1 diabetes mellitus. J Intern Med 2002, 251:69-76.
119. Visioli F., Caruso D., Galli C., Viappiani S., Galli G., Sala A. Olive oil rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun 2000, 278:769-799.
120. 2α in rat aortic rings. Prostaglandins 1997, 54:581-599.
121. Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. Placental isoprostane isoprostanes significantly increased in preeclamsia. FASEB J 2000, 14:1289-1296.
122. 2α excretion in man. J Pharmacol Exp Therap 1995, 275:94-100.
123. Weinberg R.B., VanderWerken B.S., Anderson R.A., Stegner J.E., Thomas M.J. Prooxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet. Arterioscler Throm Vasc Biol 2001, 21:1029-1033.
124. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., Garg M.L. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000, 35:967-974.